DE60033517D1 - Invivo selektionsverfahren zur bestimmung von inhibierenden rna molekülen - Google Patents

Invivo selektionsverfahren zur bestimmung von inhibierenden rna molekülen

Info

Publication number
DE60033517D1
DE60033517D1 DE60033517T DE60033517T DE60033517D1 DE 60033517 D1 DE60033517 D1 DE 60033517D1 DE 60033517 T DE60033517 T DE 60033517T DE 60033517 T DE60033517 T DE 60033517T DE 60033517 D1 DE60033517 D1 DE 60033517D1
Authority
DE
Germany
Prior art keywords
nucleotide sequence
binding
invivo
rna molecules
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60033517T
Other languages
English (en)
Other versions
DE60033517T2 (de
Inventor
Kyri Mitrophanous
Narry Howard Hughes Medica Kim
Ekaterini Kotsopoulou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Application granted granted Critical
Publication of DE60033517D1 publication Critical patent/DE60033517D1/de
Publication of DE60033517T2 publication Critical patent/DE60033517T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DE60033517T 1999-06-03 2000-06-02 Invivo selektionsverfahren zur bestimmung von inhibierenden rna molekülen Expired - Fee Related DE60033517T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9912965.2A GB9912965D0 (en) 1999-06-03 1999-06-03 In vivo selection method
GB9912965 1999-06-03
PCT/GB2000/002136 WO2000075370A1 (en) 1999-06-03 2000-06-02 In vivo selection method for determining inhibitory rna molecules

Publications (2)

Publication Number Publication Date
DE60033517D1 true DE60033517D1 (de) 2007-04-05
DE60033517T2 DE60033517T2 (de) 2007-10-25

Family

ID=10854706

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60033517T Expired - Fee Related DE60033517T2 (de) 1999-06-03 2000-06-02 Invivo selektionsverfahren zur bestimmung von inhibierenden rna molekülen

Country Status (12)

Country Link
US (2) US20020147169A1 (de)
EP (1) EP1180167B1 (de)
JP (1) JP2003501070A (de)
KR (1) KR20020008178A (de)
CN (1) CN1353769A (de)
AT (1) ATE354676T1 (de)
AU (1) AU762957B2 (de)
CA (1) CA2374664A1 (de)
DE (1) DE60033517T2 (de)
GB (2) GB9912965D0 (de)
WO (1) WO2000075370A1 (de)
ZA (1) ZA200108397B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037889B2 (en) * 2000-09-13 2006-05-02 Praecis Pharmaceuticals Inc. Pharmaceutical compositions for sustained drug delivery
AU2001294562B2 (en) * 2000-09-15 2007-05-24 Merck & Co., Inc. Enhanced First Generation Adenovirus Vaccines Expressing Codon Optimized HIV1-Gag, Pol, Nef and Modifications
SI1504108T1 (sl) 2002-02-01 2013-07-31 Oxford Biomedica (Uk) Limited Lentiviralni vektor
ATE512223T1 (de) * 2004-04-29 2011-06-15 Univ Yale Nukleaseresistente externe führungssequenzen zur behandlung von entzündlichen und virusbedingten atemwegserkrankungen
WO2012151503A2 (en) * 2011-05-04 2012-11-08 The Broad Institute, Inc. Multiplexed genetic reporter assays and compositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624824A (en) * 1989-03-24 1997-04-29 Yale University Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
WO1992001806A1 (en) * 1990-07-16 1992-02-06 The Public Health Research Institute Of The City Of New York, Inc. Selection of ribozymes that efficiently cleave target rna
US6569432B1 (en) * 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
AUPM516994A0 (en) * 1994-04-20 1994-05-12 Gene Shears Pty. Limited An in vivo gene expression system
CA2192689A1 (en) * 1994-06-15 1995-12-21 Paul B. Fisher Method to identify tumor suppressor genes
US6130092A (en) * 1994-07-04 2000-10-10 Max-Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. Ribozyme gene library and method for making
DE4424762C1 (de) * 1994-07-04 1995-07-27 Max Planck Gesellschaft Ribozym-Bibliothek, ihre Herstellung und ihre Verwendung
DE4424761C1 (de) * 1994-07-04 1995-06-08 Max Planck Gesellschaft Expressionskassette für die Antisense- und die Ribozym-Expression
EA003195B1 (ru) * 1995-11-13 2003-02-27 Такара Сузо Ко., Лтд. Способ повышения эффективности генного переноса в клетки-мишени с помощью ретровируса
AU3984497A (en) * 1996-08-16 1998-03-06 Innovir Laboratories, Inc. Phenotypic conversion of cells mediated by external guide sequences
JP4128227B2 (ja) * 1997-03-14 2008-07-30 バイオジェン・アイデック・インコーポレイテッド 哺乳類細胞内の特定部位に相同組換えによって遺伝子を組み込む方法とそれを実施するためのベクター
EP1032707A2 (de) * 1997-11-21 2000-09-06 Yale University Verfahren zur identifizierung und inhibierung funktionaler nukleinsäuremoleküle in zellen
EP1068350B1 (de) * 1998-03-28 2008-02-13 University Of Utah Research Foundation Zielgerichtete antisense-bibliotheken
US6156515A (en) * 1999-02-09 2000-12-05 Urocor, Inc. Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
GB9906177D0 (en) * 1999-03-17 1999-05-12 Oxford Biomedica Ltd Anti-viral vectors
US20020002278A1 (en) * 1999-11-05 2002-01-03 Timothy W. Nilsen Random intracellular method for obtaining optimally active nucleic acid molecules

Also Published As

Publication number Publication date
WO2000075370A1 (en) 2000-12-14
CN1353769A (zh) 2002-06-12
DE60033517T2 (de) 2007-10-25
AU5093500A (en) 2000-12-28
JP2003501070A (ja) 2003-01-14
CA2374664A1 (en) 2000-12-14
GB2364775A (en) 2002-02-06
EP1180167A1 (de) 2002-02-20
AU762957B2 (en) 2003-07-10
ATE354676T1 (de) 2007-03-15
KR20020008178A (ko) 2002-01-29
US20020147169A1 (en) 2002-10-10
GB0124449D0 (en) 2001-12-05
GB9912965D0 (en) 1999-08-04
US20050221491A1 (en) 2005-10-06
EP1180167B1 (de) 2007-02-21
ZA200108397B (en) 2002-08-28

Similar Documents

Publication Publication Date Title
Schaffner et al. Genes and spacers of cloned sea urchin histone DNA analyzed by sequencing
Lockard et al. Mapping tRNA structure in solution using double-strand-specific ribonuclease V 1 from cobra venom
Garber et al. Transcription of a cloned Bombyx mori tRNA2Ala gene: nucleotide sequence of the tRNA precursor and its processing in vitro
Barbacci et al. The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding (∗)
Bram et al. The ribonuclease III site flanking 23S sequences in the 30S ribosomal precursor RNA of E. coli
Higuchi et al. DNA sequences from the quagga, an extinct member of the horse family
BR0316435A (pt) Produtos genéticos expressos diferencialmente em tumores e uso dos mesmos
Borgatti et al. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites
Karpel et al. Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins
Young Transcription termination in the Escherichia coli ribosomal RNA operon rrnC.
Mackie Nucleotide sequence of the gene for ribosomal protein S20 and its flanking regions.
WO2004015062A3 (en) Methods and compositions relating to gene silencing
NO179412C (no) Hybrid DNA-molekyl som koder for fibronektinbindende protein, mikroorganismer inneholdende slike DNA-molekyler samt fremgangsmåte ved fremstilling av slikt protein
Razin et al. Nuclear matrix attachment regions and topoisomerase II binding and reaction sites in the vicinity of a chicken DNA replication origin
Pommier et al. Identification within the simian virus 40 genome of a chromosomal loop attachment site that contains topoisomerase II cleavage sites
Bornstein et al. Characterization of the mouse thrombospondin gene and evaluation of the role of the first intron in human gene expression.
Ho et al. Characterization of a third, cII-dependent, coordinately activated promoter on phage lambda involved in lysogenic development.
DE60033517D1 (de) Invivo selektionsverfahren zur bestimmung von inhibierenden rna molekülen
Legagneux et al. Identification of RNA-binding proteins specific to Xenopus Eg maternal mRNAs: association with the portion of Eg2 mRNA that promotes deadenylation in embryos
Dahlberg et al. Sequence of the promoter-operator proximal region of the major leftward RNA of bacteriophage lambda
Wang et al. An S1 nuclease-sensitive homopurine/homopyrimidine domain in the PDGF A-chain promoter contains a novel binding site for the growth factor-inducible protein EGR-1
Wachter et al. The leader sequence from the 5′-terminus to the A-protein initiation codon in MS2-virus RNA
BR9910787A (pt) Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src
Fang et al. Native mRNA antisense-accessible sites library for the selection of antisense oligonucleotides, PNAs, and siRNAs
Łozinski et al. Effect of the sequence-dependent structure of the 17 bp AT spacer on the strength of consensus-like E. coli promoters in vivo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee